Insmed | Eiendeler



Assets Endring Dato
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Cytokinetics USD 1.26B 137.62M 2025-03
DBV Technologies USD 65.7M 27.36M 2024-12
Dynavax Technologies USD 945.93M 40.33M 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
Insmed USD 2.03B 27.74M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
Ultragenyx Pharmaceutical USD 1.31B 191.53M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Insmed Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.